Drug Shortage Report for TEVA-BETAMETHASONE/ CALCIPOTRIOL
Report ID | 154717 |
Drug Identification Number | 02427419 |
Brand name | TEVA-BETAMETHASONE/ CALCIPOTRIOL |
Common or Proper name | BETAMET DIP/CALCIPOT OINT |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CALCIPOTRIOL BETAMETHASONE |
Strength(s) | 50MCG 0.5MG |
Dosage form(s) | OINTMENT |
Route of administration | TOPICAL |
Packaging size | 60g |
ATC code | D07XC |
ATC description | CORTICOSTEROIDS, OTHER COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-02-08 |
Estimated end date | 2022-03-31 |
Actual end date | 2022-03-31 |
Shortage status | Resolved |
Updated date | 2022-04-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-04-01 | French | Compare |
v3 | 2022-04-01 | English | Compare |
v2 | 2022-02-10 | French | Compare |
v1 | 2022-02-10 | English | Compare |
Showing 1 to 4 of 4